Avantor, Inc. AVTR
At Avantor, everything we do is tied to our unique mission of setting science in motion to create a better world. 10-K, Item 1
- Employees
- 13,500
- Headquarters
- Radnor, PA
- CEO
- Emmanuel Ligner
- Next results
- around Feb 10, 2027
Where each dollar of revenue went, FY2024
Revenue of $6.8B through the costs to a net profit of $711.5M · income statement of the 10-K
AVTR among Technology peers
Six ratios from the latest 10-K. Each corner is the share of 230 peers the company is above, not a score.
What changed
10 new risk paragraphs and 2 accounting facts worth reading about. 10-K filed Feb 11, 2026 against Feb 7, 2025.
Each row opens the detail with the quote and the filing. A row is a change worth reading, not a verdict.
Accounting checks
11 checks on the latest 10-K. Checks, not verdicts.
2facts worth reading about the other 9 checks found nothing to note
-
Inventory growing faster than revenueInventory +11.9% ($731.5M to $818.2M) vs revenue -3.4% ($6.8B to $6.6B), +15.3 pts apart
-
Critical audit matters changedNew this year: Goodwill Impairment - Distribution reporting unit (“Goodwill is tested for impairment at the reporting unit level on October 1 of each year or more frequently whenever an event or change in circumstance occurs that would require reassessment of the recoverability of the asset. The Company estimates the fair value of each reporting unit using a weight”). No longer listed: Goodwill Impairment
-
Receivables +3.9% ($1.0B to $1.1B) vs revenue -3.4% ($6.8B to $6.6B), +7.3 pts apart
8 more checks with nothing to note
-
Cash from operations $623.8M vs net income −$530.2M (FY ending Dec 31, 2025)
-
Same auditor in both 10-Ks: Deloitte & Touche LLP
-
No statement of substantial doubt about going concern
-
No 8-K item 4.02 in the last 2 years
-
No NT 10-K or NT 10-Q in the last 2 years
-
No sentence in the 10-K concludes that controls were not effective because of a material weakness
-
No 8-K item 2.06 in the last 2 years
-
No 8-K item 1.03 in the last 2 years
In their words
10 paragraphs in Risk Factors that were not in the 10-K filed Feb 7, 2025. Quoted as filed.
-
Item 1A · new paragraph · not in the 10-K filed Feb 7, 2025 10-K, ITEM 1A
Reductions in customers’ research budgets or government funding may adversely affect our business. Many of our customers are universities, government research laboratories, private foundations and other institutions that are dependent on grants from government agencies, such as the NIH, for funding. R&D spending by our customers may…
-
Item 1A · new paragraph · not in the 10-K filed Feb 7, 2025 10-K, ITEM 1A
We also face increasing attention from investors, regulators, and other stakeholders, who may have conflicting views related to our positions, performance, and disclosures relating to sustainability and corporate responsibility-related matters, and the legal and regulatory landscape continues to evolve and may result in conflicting…
-
Item 1A · new paragraph · not in the 10-K filed Feb 7, 2025 10-K, ITEM 1A
Changes in U.S. or international laws and policies governing foreign trade could materially and adversely affect our business. The U.S. has instituted certain changes, and has proposed additional changes, in trade policies that include the negotiation or termination of trade agreements, the imposition of higher tariffs on imports into…
-
Item 1A · new paragraph · not in the 10-K filed Feb 7, 2025 10-K, ITEM 1A
Our business could be impacted as a result of actions by activist shareholders or others. We have in the past and may in the future be the focus of shareholder activism, which has become increasingly prevalent. Shareholder activism, particularly with respect to matters that our Board, in exercising its fiduciary duties, disagrees with,…
New risk paragraphs, against peers
Latest 10-K of each, Technology companies closest in revenue
Paragraphs in Risk Factors with nothing like them in the company's 10-K the year before. A count of text, not of risk.
Financial performance
Last 4 fiscal years · 10-K XBRL
| Metric | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|
| Revenue | $7.5B | $7.0B | $6.8B | $6.6B |
| Net income | $686.5M | $321.1M | $711.5M | −$530.2M |
| Operating cash flow | $843.6M | $870.0M | $840.8M | $623.8M |
| Free cash flow | $710.2M | $723.6M | $692.0M | $495.0M |
Revenue, FY2017 to FY2025
Ten fiscal years, each from its own 10-K · XBRL · USD
$6.6B ▼ 3.4% in FY2025−$530.2M in FY2025$495.0M ▼ 28.5% in FY2025
Recent filings
3 filings in the last 30 days · SEC EDGAR
-
8-KNov 3, 2026Director or officer change 8-K item 5.02
-
8-KOct 28, 2026Quarterly results 8-K item 2.02
-
10-QOct 28, 2026Quarterly report (10-Q) period ended Sep 30, 2026
About the company
Avantor, Inc., Radnor, PA · from the 10-K filed Feb 11, 2026
At Avantor, everything we do is tied to our unique mission of setting science in motion to create a better world. We are a leading global provider of mission-critical products and services to customers in the biopharma & healthcare, education & government, and advanced technologies & applied materials end markets. Our business model is grounded in supporting our customers from discovery to delivery and Avantor is embedded in virtually every stage of the most important research, scale-up and manufacturing activities in the industries we serve.
- Headquarters
- Radnor, PA
- Country
- United States
- Reports in
- USD
- Listed on
- NYSE
- Fiscal year ends
- December 31
- Last results
- Oct 28, 2026
Employees, at the top of the page: "As of December 31, 2025, we had approximately 13,500 employees located in over 30 different countries in a variety of roles" (10-K). Address and exchange: SEC's company file.
Email alerts
Sources
The 10-K filed Feb 11, 2026 (open at SEC), compared with the 10-K filed Feb 7, 2025. Numbers from the XBRL of the 10-Ks; filings from SEC EDGAR.
Work with it: Excel workbook · CSV. Google Sheet that stays up to date: paste =IMPORTDATA("https://tickdelta.com/company/AVTR/export.csv") into a cell.